Detalhe da pesquisa
1.
Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
Blood
; 142(22): 1871-1878, 2023 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37494698
2.
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma.
Anticancer Drugs
; 35(1): 63-69, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067996
3.
Sarcopenia identified by computed tomography imaging using a deep learning-based segmentation approach impacts survival in patients with newly diagnosed multiple myeloma.
Cancer
; 129(3): 385-392, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36413412
4.
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival.
Am J Hematol
; 98(3): 413-420, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588396
5.
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
Am J Hematol
; 98(8): 1277-1285, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334773
6.
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
Am J Hematol
; 98(10): 1540-1549, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37421603
7.
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation.
Am J Hematol
; 97(4): 401-410, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35015310
8.
Prognostic significance of acquired 1q22 gain in multiple myeloma.
Am J Hematol
; 97(1): 52-59, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34710241
9.
Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.
Am J Hematol
; 97(1): 90-98, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34699616
10.
Characterization and prognostic implication of delayed complete response in AL amyloidosis.
Eur J Haematol
; 106(3): 354-361, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33230879
11.
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials.
Am J Hematol
; 96(9): 1131-1136, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115387
12.
Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohort.
Am J Hematol
; 96(4): 446-454, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33428787
13.
Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 26(8): 1402-1405, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32422250
14.
Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis.
Am J Hematol
; 95(5): 497-502, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32010993
15.
Refining amyloid complete hematological response: Quantitative serum free light chains superior to ratio.
Am J Hematol
; 95(11): 1280-1287, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32681737
16.
Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia.
Am J Hematol
; 95(6): 637-642, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32129510
17.
Characteristics of late transplant-associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation.
Am J Hematol
; 95(10): 1170-1179, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32618000
18.
Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells.
Am J Hematol
; 95(3): 310-315, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31867775
19.
Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved.
Biol Blood Marrow Transplant
; 25(8): 1520-1525, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31054986
20.
Ten-year survivors in AL amyloidosis: characteristics and treatment pattern.
Br J Haematol
; 187(5): 588-594, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31298751